Arie Gutman
About Arie Gutman
Arie Gutman President of API
Arie Gutman holds the position of President at API. His leadership involves overseeing the development, manufacture, and marketing of specialty active pharmaceutical ingredients (APIs). With extensive experience in the pharmaceutical industry, Arie Gutman plays a crucial role in steering API towards innovation and growth.
Founder of FineTech Pharmaceuticals
In 1990, Arie Gutman founded FineTech Pharmaceuticals, a company specializing in the development, manufacture, and marketing of specialty active pharmaceutical ingredients (APIs). His initiative led FineTech Pharmaceuticals to become notable in the pharmaceutical industry, particularly in the field of API development.
Academic Career at Technion - Israel Institute of Technology
From 1992 to 2003, Arie Gutman served as a Professor of Organic Chemistry at Technion - Israel Institute of Technology. During his tenure, he contributed to the academic community through teaching, research, and publication of numerous scholarly articles. His academic role further solidified his expertise in organic chemistry.
Fellowship at Churchill College, Cambridge
Since 1987, Arie Gutman has been a Fellow of Churchill College, Cambridge. This fellowship recognizes his contributions to the field of chemistry and his ongoing commitment to academic excellence. His affiliation with Churchill College highlights his global academic presence and collaboration.
Educational Background of Arie Gutman
Arie Gutman earned his bachelor's degree from Hebrew University, followed by an M.Sc. from Technion - Israel Institute of Technology. He later completed his Ph.D. at Cambridge University. This extensive educational background laid the foundation for his career in organic chemistry and pharmaceutical research.